A new study from researchers at the University of Chicago provides important insight into how the pancreas protects itself during inflammation, pointing to promising new directions for treating pancreatitis.
May 25, 2026
0
8
Respiratory syncytial virus (RSV) is a common respiratory virus that can cause severe breathing complications in babies, especially those younger than 6 months old. While many adults recover quickly from RSV with mild symptoms ...
A new type of cell therapy shows promise as the first treatment for advanced liver disease, following results from a clinical trial. Patients with the condition who were treated with the cell therapy had a significantly lower ...
May 25, 2026
0
7
Pulse oximeter devices routinely overestimate blood oxygen levels in darker-skinned patients—a racial bias that can trigger downstream health harms for Black individuals, compounding well beyond any single inaccurate reading.
May 25, 2026
1
6
Substantial and sustained weight loss has been linked to a reduced risk of cancer and cancer-related death, mainly in women. Two new studies now provide clues to why the risk is reduced—and suggest that gender, metabolism ...
May 25, 2026
0
4
A new study finds that an interdisciplinary, individualized approach to pain management, including coaching support and health goal planning, may reduce the impact of chronic pain on veterans. The findings are published in ...
May 25, 2026
0
4
Dr. Jeffery Taubenberger, who has been serving as acting head of the National Institute for Allergy and Infectious Diseases (NIAID) for just over a year, has stepped down for unknown reasons.
May 25, 2026
0
21
By the second week of the latest Ebola outbreak in the Democratic Republic of Congo, it was already clear that containing the spread of the hemorrhagic disease was proving to be difficult.
May 25, 2026
1
27
Australia became the first country to prohibit those under age 16 from using major social media platforms in December 2025. The aim was to limit the potentially harmful cognitive, social, and mental health effects on children. ...
May 25, 2026
0
8
The U.S. Food and Drug Administration has approved AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) for both the neoadjuvant and adjuvant treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive ...
May 25, 2026
0
8
